Dr William Schwieterman joins Chelsea Therapeutics
This article was originally published in Scrip
Executive Summary
Dr William Schwieterman has joined the board of directors at Chelsea Therapeutics(US). Dr Schwieterman, a board-certified internist and a rheumatologist, was formerly chief of the medicine branch and chief of the immunology and infectious disease branch in the division of clinical trials at the FDA.